Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Fox

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Haematologica|October 1, 2016
Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyureaAlberto Alvarez-Larrán, Manuel Pérez-Encinas, Francisca Ferrer-Marín, et al.
Transplantation and Cellular Therapy|January 14, 2026
Haploidentical Donor vs. Mismatched Unrelated Donor in Reduced-Intensity Conditioning Stem Cell Transplant, a GETH-TC StudyMaría Laura Fox, Ariadna Pérez Martínez, Albert Esquirol, et al.
British Journal of Haematology|April 29, 2026
Prospective implementation of the HCT frailty scale in adults with lymphoproliferative syndromes candidates for autologous haematopoietic stem cell transplantation: Results from a multicentre GETH-TC studyJavier Cornago, Mónica Baile, Marina Acera, et al.
Cancer|April 13, 2022
Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyureaAlberto Alvarez-Larrán, Marta Garrote, Francisca Ferrer-Marín, et al.
British Journal of Haematology|September 12, 2022
Predictors of thrombosis and bleeding in 1613 myelofibrosis patients from the Spanish Registry of MyelofibrosisJuan-Carlos Hernández-Boluda, Irene Pastor-Galán, Eduardo Arellano-Rodrigo, et al.
American Journal of Hematology|October 17, 2025
Coexisting Myeloproliferative and Lymphoid Neoplasms: A European Multicenter Retrospective StudyDolly Viviana Fiallo-Suárez, Ruth Stuckey, Cristina Bilbao-Sieyro, et al.
Plos One|February 6, 2013
Genetic diversity in the modern horse illustrated from genome-wide SNP dataJessica L Petersen, James R Mickelson, E Gus Cothran, et al.
Hemasphere|December 26, 2022
Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of MyelofibrosisAdrián Mosquera-Orgueira, Manuel Pérez-Encinas, Alberto Hernández-Sánchez, et al.
Annals of Hematology|November 24, 2022
Philadelphia-negative chronic myeloproliferative neoplasm follow-up: when the phone rings. Changes during the COVID-19 pandemic and patient satisfaction. Experience in 30 health centers in SpainAriana Ortuzar, María Laura Fox, Juan Antonio Vera, et al.
Blood|December 24, 2019
Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control studyValerio De Stefano, Arianna Ghirardi, Arianna Masciulli, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Haematologica|October 1, 2016
Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyureaAlberto Alvarez-Larrán, Manuel Pérez-Encinas, Francisca Ferrer-Marín, et al.
Transplantation and Cellular Therapy|January 14, 2026
Haploidentical Donor vs. Mismatched Unrelated Donor in Reduced-Intensity Conditioning Stem Cell Transplant, a GETH-TC StudyMaría Laura Fox, Ariadna Pérez Martínez, Albert Esquirol, et al.
British Journal of Haematology|April 29, 2026
Prospective implementation of the HCT frailty scale in adults with lymphoproliferative syndromes candidates for autologous haematopoietic stem cell transplantation: Results from a multicentre GETH-TC studyJavier Cornago, Mónica Baile, Marina Acera, et al.
Cancer|April 13, 2022
Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyureaAlberto Alvarez-Larrán, Marta Garrote, Francisca Ferrer-Marín, et al.
British Journal of Haematology|September 12, 2022
Predictors of thrombosis and bleeding in 1613 myelofibrosis patients from the Spanish Registry of MyelofibrosisJuan-Carlos Hernández-Boluda, Irene Pastor-Galán, Eduardo Arellano-Rodrigo, et al.
American Journal of Hematology|October 17, 2025
Coexisting Myeloproliferative and Lymphoid Neoplasms: A European Multicenter Retrospective StudyDolly Viviana Fiallo-Suárez, Ruth Stuckey, Cristina Bilbao-Sieyro, et al.
Plos One|February 6, 2013
Genetic diversity in the modern horse illustrated from genome-wide SNP dataJessica L Petersen, James R Mickelson, E Gus Cothran, et al.
Hemasphere|December 26, 2022
Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of MyelofibrosisAdrián Mosquera-Orgueira, Manuel Pérez-Encinas, Alberto Hernández-Sánchez, et al.
Annals of Hematology|November 24, 2022
Philadelphia-negative chronic myeloproliferative neoplasm follow-up: when the phone rings. Changes during the COVID-19 pandemic and patient satisfaction. Experience in 30 health centers in SpainAriana Ortuzar, María Laura Fox, Juan Antonio Vera, et al.
Blood|December 24, 2019
Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control studyValerio De Stefano, Arianna Ghirardi, Arianna Masciulli, et al.
Pageof 9